This most recent twist within the Lykos Therapeutics saga threatens a major overhaul of the corporate’s approach and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to would like to just take the corporate back toward its nonprofit drug progress roots and a far more Doblinite philosophy.For instance, this patent could r